京玖康疗(00648)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00648 京玖康疗

未开盘 10-07 16:08:50

0.465

+0.025

+5.68%

最高0.485	最低0.415	成交量58.65万
今开0.415	昨收0.440	日振幅15.91%
总市值4,980万	流通市值4,980万	总股本1.07亿
成交额27.12万	换手率0.55%	流通股本1.07亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00648","market":"HK","secType":"STK","nameCN":"京玖康疗","latestPrice":0.465,"timestamp":1791360530394,"preClose":0.44,"halted":0,"volume":586500,"delay":0,"changeRate":0.05681818181818187,"floatShares":107100000,"shares":107100000,"eps":0.24,"marketStatus":"未开盘","change":0.025,"latestTime":"10-07 16:08:50","open":0.415,"high":0.485,"low":0.415,"amount":271186,"amplitude":0.159091,"askPrice":0.47,"askSize":4000,"bidPrice":0.465,"bidSize":57000,"shortable":0,"etf":0,"ttmEps":0.077,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791423000000},"marketStatusCode":0,"adr":0,"listingDate":657129600000,"exchange":"SEHK","adjPreClose":0.44,"openAndCloseTimeList":[[1791336600000,1791345600000],[1791349200000,1791360000000]],"volumeRatio":0.412425,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00648","defaultTab":"news","newsList":[{"id":"1194016622","title":"京玖康疗2026年9月股份变动月报表：股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1194016622","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194016622?lang=zh_cn&edition=full","pubTime":"2026-10-02 18:55","pubTimestamp":1790938533,"startTime":"0","endTime":"0","summary":"京玖醫療健康有限公司于2026年10月2日披露了截至2026年9月30日止月份的证券变动月报。根据公告，本月公司法定/注册股本并无变动，已发行股份总数为107,116,933股，与上月持平，未发生新增发行、购回或注销，亦无任何库藏股数变化。同时，报告期内未见任何股份期权、权证及其他股份激励计划的变动，也无已发行股份或库藏股的增减记录。截至2026年9月底，公司公众持股量符合相关要求，股本保持稳定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126864603","title":"京玖康疗（00648）高层人事调整：梁家豪接任公司秘书及授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=1126864603","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126864603?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:35","pubTimestamp":1790764549,"startTime":"0","endTime":"0","summary":"董事会向林崇谦先生在任期间对公司的贡献表示感谢，并祝其退休生活愉快。截至公告日，京玖康疗董事会成员包括执行董事林品卓先生，以及独立非执行董事乐可慰先生、唐萃环女士及姚俊荣先生。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671203043","title":"京玖康疗(00648)：梁家豪获委任为公司秘书及授权代表","url":"https://stock-news.laohu8.com/highlight/detail?id=2671203043","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671203043?lang=zh_cn&edition=full","pubTime":"2026-09-30 18:35","pubTimestamp":1790764524,"startTime":"0","endTime":"0","summary":"智通财经APP讯，京玖康疗(00648)发布公告，自2026年9月30日起：(i)林崇谦先生已辞任公司秘书及授权代表;及(ii)梁家豪先生已获委任为公司秘书及授权代表。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00648","02951","BK1511","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102517283","title":"京玖康疗2026年8月股份变动月报表，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1102517283","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1102517283?lang=zh_cn&edition=full","pubTime":"2026-09-03 16:11","pubTimestamp":1788423113,"startTime":"0","endTime":"0","summary":"京玖醫療健康有限公司（简称“京玖康疗”）于2026年9月3日发布2026年8月股份变动月报表。截至8月31日，公司普通股已发行股份总数为107,116,933股，与上月底相同，注册股本未发生变化。报告期内未出现新增发行、购回或注销等股份变动。\n公告显示，截至本月末，京玖康疗已发行股份数量及公众持股量均符合香港联合交易所有限公司规定。公司并无任何股份期权、购回和期权激励计划的变动事项披露。\n公司方面确认已遵守香港联交所《上市规则》及其他适用法律法规的要求。本次月报由公司秘书林崇谦签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1139400739","title":"京玖康疗2026年中期业绩营收34.10百万元，经调整净利润4.60百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1139400739","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1139400739?lang=zh_cn&edition=full","pubTime":"2026-08-11 06:12","pubTimestamp":1786399935,"startTime":"0","endTime":"0","summary":"截至2026年6月30日止六个月，京玖康疗实现营收34.10百万元，同比下降约4.7%。同期，经调整净利润4.60百万元，同比上升约35.3%。毛利率为27.7%，相比上年同期32.1%有所下降，主要系产品组合变化所致。期间经营活动产生的净现金流为15.20百万元，相较于上年同期的1.70百万元大幅增长。管理层表示，行政开支较上年同期减少20.8%，主要由于成本管控措施取得成效，同时本期无重大法律及专业费用。报告期内，医疗及健康板块的营收为34.10百万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"京玖康疗2026年中期业绩营收34.10百万元，经调整净利润4.60百万元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658939384","title":"京玖康疗(00648)公布中期业绩 净利464.8万港元 同比增长38.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658939384","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658939384?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:37","pubTimestamp":1786365452,"startTime":"0","endTime":"0","summary":"智通财经APP讯，京玖康疗(00648)公布2026年中期业绩，收益 3407.5万港元，同比减少4.74%;净利464.8万港元，同比增长38.62%;每股溢利4.4港仙。公告称，溢利增加主要归因于以下因素：行政开支减少，无按公平值计入损益的金融资产的公平值变动产生的亏损。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1478167.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02951","BK1219","BK1511","00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142145007","title":"京玖康疗（00648）公布2026年中期业绩　净利同比增35.3%至460万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142145007","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1142145007?lang=zh_cn&edition=full","pubTime":"2026-08-10 20:35","pubTimestamp":1786365342,"startTime":"0","endTime":"0","summary":"京玖康疗8月10日披露截至2026年6月30日止六个月未经审计中期业绩。期内，公司拥有人应占溢利由2025年同期的340万港元增至460万港元，同比增长35.3%。行政开支下降20.8%至360万港元；期内未产生按公平值计入损益金融资产的公平值亏损。融资成本为36万港元。受股份合并影响，截至2026年6月30日，已发行股份数目为1.07亿股，已发行股本30.49亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127018217","title":"京玖康疗2026年7月股份变动月报表，股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1127018217","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127018217?lang=zh_cn&edition=full","pubTime":"2026-08-04 16:37","pubTimestamp":1785832676,"startTime":"0","endTime":"0","summary":"京玖医疗健康有限公司于2026年8月4日披露的截至2026年7月31日止股份变动月报表显示，公司在本报告期内未进行新增发行、回购、注销或库藏股活动。截至2026年7月31日，公司普通股已发行股份总数为107,116,933股，较上月底保持不变，无注册股本变动，库存股份数为0股。公司确认符合香港联交所要求的最低公眾持股量门槛，股本结构在报告期内维持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178371807","title":"京玖康疗（00648）将于8月10日审议截至6月底的中期业绩","url":"https://stock-news.laohu8.com/highlight/detail?id=1178371807","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178371807?lang=zh_cn&edition=full","pubTime":"2026-07-29 19:06","pubTimestamp":1785323172,"startTime":"0","endTime":"0","summary":"京玖康疗（00648）董事会宣布，拟于2026年8月10日（星期一）召开会议，审议及批准公司及其附属公司截至2026年6月30日止六个月的未经审核中期业绩。\n根据公告，会议召开日期由公司秘书林崇谦代表董事会于2026年7月29日发布。目前，公司董事会成员包括执行董事林品卓先生，以及独立非执行董事乐可慰先生、唐萃环女士及姚俊荣先生。\n公司表示，将在董事会会议后适时公布中期业绩报告。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650912847","title":"京玖康疗(00648.HK)转仓市值总计792.57万港元 占比9.13% 股东从花旗银行转出375.73万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2650912847","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650912847?lang=zh_cn&edition=full","pubTime":"2026-07-09 08:22","pubTimestamp":1783556563,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["00648","02951","BK1511","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185959309","title":"京玖康疗6月无新增发行或股份变动","url":"https://stock-news.laohu8.com/highlight/detail?id=1185959309","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185959309?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:18","pubTimestamp":1783333090,"startTime":"0","endTime":"0","summary":"京玖醫療健康有限公司于2026年7月6日发布截至2026年6月30日的证券变动月报表。报告显示，公司上月底和本月底的已发行股份数量均为107,116,933股，无新增发行或回购注销行为，股本结构与上月相比保持一致。公司同时在公告中表示，所有金融活动均经过董事会正式授权，严格遵守香港联交所《上市规则》及相关法律要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647839365","title":"京玖康疗(00648)存仓市值总计3537.53万港元 占比5.41% 股东将535.40万股股票存入大华继显(香港)","url":"https://stock-news.laohu8.com/highlight/detail?id=2647839365","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647839365?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:24","pubTimestamp":1782779047,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，6月29日，京玖康疗出现仓位异动，存仓市值总计3537.53万港元，占比5.41%。该公司股东将535.40万股股票存入大华继显(香港)，持股比例增加5%。京玖康疗此前公布，有关公司控股股东Multi Omniverse Group Limited拟配售所持有最多4.45亿股公司股份，于2026年5月15日，公司获配售股东通知，其所持有的全部4.45亿股公司股份已由配售代理以每股配售股份0.11港元的配售价，配售予不少于6名承配人。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460880.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00648","02951","BK1511","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647341374","title":"京玖康疗(00648)存仓市值总计3307.09万港元 占比5.1% 其中股东向大华继显(香港)存入500.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647341374","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647341374?lang=zh_cn&edition=full","pubTime":"2026-06-29 08:16","pubTimestamp":1782692184,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，6月26日，京玖康疗出现仓位异动，存仓市值总计3307.09万港元，占比5.1%。京玖康疗公告，有关公司控股股东Multi Omniverse Group Limited拟配售所持有最多4.45亿股公司股份，于2026年5月15日，公司获配售股东通知，其所持有的全部4.45亿股公司股份已由配售代理以每股配售股份0.11港元的配售价，配售予不少于6名承配人。完成配售后，配售股东于公司的权益由51.0%降至30.3%，仍为公司的控股股东。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","02951","00648","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1127165583","title":"京玖康疗更新5月股份变动月报表，股本因股份合并大幅减少","url":"https://stock-news.laohu8.com/highlight/detail?id=1127165583","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1127165583?lang=zh_cn&edition=full","pubTime":"2026-06-01 19:42","pubTimestamp":1780314132,"startTime":"0","endTime":"0","summary":"京玖康疗于2026年6月1日发布了截至2026年5月31日的证券变动月报表。公告显示，公司在报告期内实施了按每20股合并为1股合并股份的举措，已发行普通股数量从上月底的2,142,338,669股减少2,035,221,736股至5月底的107,116,933股，库存股份数量报0股。截至2026年5月31日，京玖康疗已发行股份总数变动后为107,116,933股。公司在公告中表示，上述全部事项均已获得董事会批准，并遵守香港交易及结算所有限公司证券上市规则及相关法律规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635081554","title":"京玖康疗(00648)：控股股东完成配售4.45亿股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2635081554","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635081554?lang=zh_cn&edition=full","pubTime":"2026-05-15 19:50","pubTimestamp":1778845805,"startTime":"0","endTime":"0","summary":"智通财经APP讯，京玖康疗 发布公告，有关公司控股股东Multi Omniverse Group Limited拟配售所持有最多4.45亿股公司股份，于2026年5月15日，公司获配售股东通知，其所持有的全部4.45亿股公司股份已由配售代理以每股配售股份0.11港元的配售价，配售予不少于6名承配人。完成配售后，配售股东于公司的权益由51.0%降至30.3%，仍为公司的控股股东。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1442419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1219","00648","BK1511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106358522","title":"京玖康疗股东特别大会通过股份合并决议 5月19日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=1106358522","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106358522?lang=zh_cn&edition=full","pubTime":"2026-05-15 19:42","pubTimestamp":1778845376,"startTime":"0","endTime":"0","summary":"京玖康疗发布公告称，公司于2026年5月15日举行的股东特别大会上，正式通过了股份合并相关决议案。据公告披露，截至股东特别大会召开当日，公司已发行股份总数为21.42亿股，均赋予股东出席会议并投票的权利。公告显示，股份合并将在获得联交所批准上市后，于2026年5月19日（星期二）生效，合并股份同日上午9时起开始在联交所买卖。本次股东特别大会的监票人为公司股份登记处卓佳证券登记有限公司，全体董事均出席了会议。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"京玖康疗股东特别大会通过股份合并决议 5月19日正式生效","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635508897","title":"京玖康疗(00648)股东将股票存入宏智证券 存仓市值1.03亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2635508897","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2635508897?lang=zh_cn&edition=full","pubTime":"2026-05-14 08:17","pubTimestamp":1778717840,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，香港联交所最新资料显示，5月13日，京玖康疗股东将股票存入宏智证券，存仓市值1.03亿港元，占比9.66%。京玖康疗4月29日公布，公司控股股东Multi Omniverse Group Limited已于2026年4月29日与一家配售代理订立配售协议，拟透过配售代理出售所持最多5亿股公司股份，每股配售股份0.11港元，售期自配售协议日期起至2026年5月8日止，或由配售股东与配售代理书面协定的较长期间。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1441494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1511","00648","161027","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633438731","title":"港股京玖康疗涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633438731","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633438731?lang=zh_cn&edition=full","pubTime":"2026-05-08 15:46","pubTimestamp":1778226404,"startTime":"0","endTime":"0","summary":"5月8日，京玖康疗(00648.HK)涨超6%，截至发稿涨6.02%，报0.44港元，成交额5139.51万港元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605083731462050.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605083731462050.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1511","00648","VXUS","BK4588","BK1219","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633128149","title":"京玖康疗(00648)：控股股东完成配售现有股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2633128149","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2633128149?lang=zh_cn&edition=full","pubTime":"2026-05-07 21:30","pubTimestamp":1778160638,"startTime":"0","endTime":"0","summary":"智通财经APP讯，京玖康疗 发布公告，于2026年5月7日，本公司获配售股东通知，其所持有的全部5亿股本公司股份已由配售代理以每股配售股份0.11港元的配售价，配售予不少于 6名承配人。完成配售后，配售股东于本公司的权益由74.4%降至51.0%，仍为本公司的控股股东。本公司预期配售不会对本公司及其附属公司的业务运作造成任何不利影响。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1439253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00648","BK1511","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132322561","title":"京玖康疗4月股份变动月报：新增发行16,301,841股","url":"https://stock-news.laohu8.com/highlight/detail?id=1132322561","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132322561?lang=zh_cn&edition=full","pubTime":"2026-05-06 18:57","pubTimestamp":1778065030,"startTime":"0","endTime":"0","summary":"京玖醫療健康有限公司于2026年5月4日发布2026年4月股份变动月报表。公告显示，公司注册股本本月无变化，截至2026年4月30日，充分满足香港联交所相关公众持股量要求。本月股本结构方面，京玖康疗普通股于月初已发行股数为2,126,036,828股。报告期内，因配发及发行计划股份，新增发行16,301,841股，发行价格为每股港币0.01元。截至2026年4月30日，公司普通股已发行股份总数增加至2,142,338,669股，库藏股数量为0股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00648"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.chinawahyan.com","stockEarnings":[{"period":"1week","weight":0.0941},{"period":"1month","weight":-0.0971},{"period":"3month","weight":-0.5},{"period":"6month","weight":-0.9184},{"period":"1year","weight":-0.9472},{"period":"ytd","weight":-0.875}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":-0.0505},{"period":"3month","weight":0.0042},{"period":"6month","weight":-0.0681},{"period":"1year","weight":-0.1049},{"period":"ytd","weight":-0.0585}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"京玖医疗健康有限公司（原名：中国华仁医疗有限公司）是一家主要从事医疗保健业务的投资控股公司。该公司通过三个部门运营。医疗及健康生活业务分部从事经营肿瘤专科诊断治疗的连锁医疗中心。该分部亦从事经营眼镜产品及眼睛护理服务的连锁零售店。该分部亦从事制造及销售医药及保健相关产品。此外，该分部从事提供提供医学实验室检测服务，健康检查服务以及妇产科服务。运动及健康业务分部从事经营连锁运动及健康会所俱乐部。资产管理业务分部从事金融资产、固定资产不良资产及贷款融资。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":0.954788},{"month":2,"riseRate":0.615385,"avgChangeRate":0.079973},{"month":3,"riseRate":0.32,"avgChangeRate":-0.040357},{"month":4,"riseRate":0.5,"avgChangeRate":0.069738},{"month":5,"riseRate":0.538462,"avgChangeRate":0.12833},{"month":6,"riseRate":0.230769,"avgChangeRate":-0.097788},{"month":7,"riseRate":0.307692,"avgChangeRate":-0.046944},{"month":8,"riseRate":0.115385,"avgChangeRate":-0.088311},{"month":9,"riseRate":0.384615,"avgChangeRate":0.008746},{"month":10,"riseRate":0.538462,"avgChangeRate":-0.017091},{"month":11,"riseRate":0.384615,"avgChangeRate":-0.042926},{"month":12,"riseRate":0.24,"avgChangeRate":-0.034827}],"exchange":"SEHK","name":"京玖康疗","nameEN":"SOFTMEDX-NEW"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"京玖康疗(00648)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供京玖康疗(00648)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"京玖康疗,00648,京玖康疗股票,京玖康疗股票老虎,京玖康疗股票老虎国际,京玖康疗行情,京玖康疗股票行情,京玖康疗股价,京玖康疗股市,京玖康疗股票价格,京玖康疗股票交易,京玖康疗股票购买,京玖康疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"京玖康疗(00648)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供京玖康疗(00648)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}